Journal of the American Medical Association

Biogen biologics plant in Denmark

Biotech

FDA advisers tear apart case for Biogen's aducanumab

The JAMA article restates the case against aducanumab ahead of a June decision by the FDA on whether to approve the closely watched medicine.

Nick Paul Taylor Apr 1, 2021 7:45am

A woman in a face mask appears upset

Cancer trials a major victim of pandemic: JAMA

Feb 9, 2021 7:35am

FDA Building 2

FDA de novo pathway clearing devices without enough evidence

Oct 23, 2020 9:15am

Robert Califf

FDA under fire over accelerated approval data demands

Aug 16, 2017 8:45am